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Background:Coffee consumption has been reported to
be inversely associated with risk of type 2 diabetes melli-
tus. Similar associations have also been reported for de-
caffeinated coffee and tea.We report herein the findings
of meta-analyses for the association between coffee, de-
caffeinated coffee, and tea consumption with risk of dia-
betes.
Methods:Relevant studieswere identified through search
engines using a combined text word and MeSH (Medi-
cal Subject Headings) search strategy. Prospective stud-
ies that reported an estimate of the association between
coffee, decaffeinated coffee, or tea with incident diabe-
tes between 1966 and July 2009.
Results: Data from 18 studies with information on
457 922 participants reported on the association be-
tween coffee consumption and diabetes. Six (N=225516)
and 7 studies (N=286 701) also reported estimates of the
association between decaffeinated coffee and teawith dia-
betes, respectively. We found an inverse log-linear rela-
tionship between coffee consumption and subsequent risk
of diabetes such that every additional cup of coffee con-
sumed in a day was associated with a 7% reduction in
the excess risk of diabetes relative risk, 0.93 [95% con-
fidence interval, 0.91-0.95]) after adjustment for poten-
tial confounders.
Conclusions:Owing to the presence of small-study bias,
our resultsmay represent an overestimate of the truemag-
nitude of the association. Similar significant and inverse
associations were observed with decaffeinated coffee and
tea and risk of incident diabetes. High intakes of coffee,
decaffeinated coffee, and tea are associated with re-
duced risk of diabetes. The putative protective effects of
these beverages warrant further investigation in random-
ized trials.
Arch Intern Med. 2009;169(22):2053-2063
B Y2025, THENUMBEROF IN IN-dividuals estimated to be af-fected by type 2 diabetesmellitus (DM) will increaseby 65% to reach an esti-
mated 380 million individuals worldwide,
with the greatest burden being shouldered
by the lower- and middle-income coun-
tries of the Asia-Pacific region.1 Diabetes
mellitus causes substantial morbidity and
mortality in those affected and is associ-
atedwith enormous economic, health, and
societal costs.2,3 Moreover, compared with
unaffected individuals, those with DM are
at greatly elevated risk of other chronic ill-
nesses, including cardiovascular disease, in
which casesDMmore thandoubles the risk
of having a heart attack or stroke.4,5 There-
fore, the identificationofmodifiable risk fac-
tors for the primary prevention of DM is of
considerable public health importance.
Despite considerable research atten-
tion, the role of specific dietary and life-
style factors remains uncertain, although
obesity6,7 and physical inactivity8 have con-
sistently been reported to raise the risk of
DM. Observational epidemiologic studies
have also suggested that high dietary in-
takes of fat, especially trans-fats,9 and red
meat10,11 are independently associatedwith
reduced insulin sensitivity and increased
risk of DM, and conversely, that high in-
takes of whole grains may be protec-
tive.5,9,12 Other studies have highlighted the
potential role that high intakes of coffee and
teamay have on reducing the likelihood of
developing DM.
An earlier meta-analysis suggested that
individuals with the highest level of cof-
fee consumption have approximately one-
third the risk of DM compared with those
with the lowest levels of consumption.13
However, since that review was pub-
lished, the amount of information that is
now available on the relationship be-
tween coffee consumption and subse-
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quent risk of DM has more than
doubled.14-24 Furthermore, several
studies have also published data sug-
gesting that decaffeinated coffee and
tea may confer benefits similar to
those of regular coffee consump-
tion, although there has been no sys-
tematic evaluation of the evidence
for these beverages.16,17 Hence, the
purpose of the current report is to
update the previousmeta-analysis of
the association between coffee con-
sumption and risk ofDMand to con-
duct a supplementary overview of
the evidence for decaffeinated cof-
fee and tea consumption on subse-
quent risk.
METHODS
LITERATURE SEARCH
We performed a systematic review of
available literature according to the
MOOSE guidelines.25 Relevant studies
published between 1966 and July 2009
were identified fromCINAHL, EMBASE,
PubMed, and theCochraneLibraryusing
a combined text and the followingMeSH
heading search strategies: (caffeine OR
coffee OR decaffeinated OR tea) AND
(diabetes OR NIDDM OR adult-onset
diabetes OR glucose) AND (cohort OR
case-control). References from these
studies, as well from the previous re-
views, were also scrutinized to identify
other relevant studies. Therewas no lan-
guage restriction.
STUDY SELECTION
AND DATA EXTRACTION
Studies were included in this system-
atic review if they had published quan-
titative estimates (including variability)
of the association between intake of
total coffee, decaffeinated coffee, total
tea (including green and black) with
new-onset (incident) DM. Findings
had to be adjusted for at least age and
body mass index (BMI). We excluded
all animal studies and, in humans,
studies of type 1 DM. Given that a dis-
ease may plausibly affect dietary intake
(reverse causality), we also excluded
all cross-sectional studies and those
case-control studies with no informa-
tion on incident DM. Furthermore, we
excluded studies that classified con-
sumption only into a binary variable
(ie, yes or no) without specifying the
number of cups of beverage consumed
per day. The literature research and
data extraction were conducted by 2 of
the us (C.M.Y.L. and L.T.). Where
there was disagreement over the eligi-
bility of the study, 3 more of us
reviewed the article (R.H., F.B., and
S.C.), and a consensus was reached.
DATA SYNTHESIS
AND ANALYSIS
Given that most studies reported the as-
sociation between beverage consump-
tion and DM formore than 1 level of in-
take, an a priori decision was made to
pool the estimates of relative risk (RR)
that corresponded as closely as pos-
sible to between 3 and 4 cups of coffee,
decaffeinated coffee, or tea per day, com-
pared with none. A test for linear trend
of effects across coffee consumption cat-
egorieswas performedby regressing each
log RR on the ordered categorical vari-
able for coffee in 5 levels using a random-
effect meta-regression model. A log-
linear association between cups per day
andRRwas fitted using generalized least
squares.26
For studies of specific types of tea
(black, green, and oolong), only 1 esti-
mate of the association with DMwas re-
ported, and hence, we report on the as-
sociation with DM comparing tea
drinkers with non–tea drinkers. Sum-
mary estimates were obtained bymeans
of a random-effects model, and studies
were weighted according to an esti-
mate of statistical size defined as the in-
verse of the variance of the log RR.27 The
percentage of variability across studies
attributable to heterogeneity rather than
chance was estimated using the I2 sta-
tistic.28,29 Possible sources of heteroge-
neity were investigated by comparing
summary results obtained when stud-
ies were grouped according to statisti-
cal size, sex,method of diagnosis of DM,
and level of adjustment. Publication bias
was assessed taking, for each study, the
RR and 95% confidence interval (CI)
corresponding to the highest category of
coffee consumption using the Egger
test.30 All analyseswere performed using
Stata software, version 10 (StataCorp LP,
College Station, Texas).
RESULTS
STUDY CHARACTERISTICS
The search strategy identified a total
of 2435 articles, of which 847 were
duplicates. After a reviewof 1588 ab-
stracts, 120 reports were reviewed
in full (Figure 1), and 20 of these,
all cohort studies, were included in
our review.14-24,31-40 The sample size
ranged from 910 to 88 259 and to-
taled 517 325 individuals, among
whom there were 21 897 cases of
new-onset DM (Table). Cohorts
were drawn from diverse popula-
tions, including Singapore,20 Puerto
Rico,15 the United Kingdom,17
Finland, 1 4 , 1 8 , 3 1 , 3 2 the United
States,16,21-23,34-36 Japan,17,40 the Neth-
erlands,38,39 and Sweden33 but in-
cluded predominantly white popu-
lations, with 21%of the data derived
from Asian cohorts (n=110 147).
The studies represented both the
general population and specific
occupational groups. Age at com-
mencement of the studies ranged
from 20 to 98 years, and the me-
dian duration of follow-up ranged
from 2 to 20 years.
MEASUREMENT OF EXPOSURE
AND OUTCOME
Apart from 1 study, which used 24-
hour dietary recall to obtain an es-
timate of coffee consumption,15 all
of the remaining studies used self-
reported food frequency or self-
administered questionnaires. Dia-
betesmellitus was ascertained using
self-report of physician diagnoses,
routinely collected hospital admis-
sion records, or direct measure-
ment using an oral glucose toler-
ance test. Studies quantified the
association between beverage in-
take and DM using RR with accom-
2435
1037
1251
147
Overall results of database searching
MEDLINE
EMBASE
CINAHAL
847 Duplicates
1588 Abstracts reviewed
1447 Not observational studies 
or no relevant outcomes
120 Full articles reviewed
87
12
2
Association of coffee, tea, or 
caffeine with type 2 diabetes 
mellitus not examined
Not cohort study
Not usable estimate
20 Studies included
Figure 1. Flowchart for identifying eligible
studies.
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panying 95% CIs. With few ex-
ceptions, all studies controlled
extensively for a range of potential
confounders. Although some stud-
ies recruited men and women, not
all reported sex-specific analyses;
those that did were entered sepa-
rately into themeta-analysis, result-
ing in a total of 37 estimates of the
relationship between coffee, decaf-
feinated coffee, and tea with risk of
DM.
ASSOCIATION BETWEEN
COFFEE CONSUMPTION
AND DM
A total of 23 estimates from 18 stud-
ies (5 studies reported sex-specific
Table. Characteristics of Studies Reporting on the Association Between Coffee, Decaffeinated Coffee, or Tea
and Subsequent Type 2 DM
Source Sex
Age
Range,
y
Study Size,
No. of
Subjects
DM
Event,
No.
Follow-up,
y
Assessment
of DM
Variables
in Multiple
Adjustment Beverage Consumptiona
Multivariate
Adjusted
RR
(95% CI)
Kato et al,40 2009,
Japan ( JPHC
Study Cohort)
M 40-69 24 826 1601 10 SR Age, BMI, smoking,
alcohol, family
history, PA, HT,
mental stress
Coffee Almost never
1-2/wk
3-4/wk
1-2
3-4
5
1 [Reference]
0.93 (0.80-1.08)
0.84 (0.71-1.01)
0.84 (0.73-0.97)
0.83 (0.68-1.02)
0.82 (0.60-1.11)
F 31 000 1093 Almost never
1-2/wk
3-4/wk
1-2
3-4
5
1 [Reference]
0.90 (0.76-1.06)
0.95 (0.77-1.17)
0.81 (0.69-0.96)
0.62 (0.45-0.84)
0.40 (0.20-0.78)
Odegaard et al,20 2008,
Singapore
(Singapore Chinese
Health Study)
M and F 45-74 36 908 1889 5.7 SR Age, year of
interview, sex,
dialect, education,
HT, smoking,
alcohol, BMI, PA,
dietary variables
Coffee Nondaily
1
2-3
4
1 [Reference]
0.96 (0.86-1.08)
0.90 (0.79-1.2)
0.70 (0.53-0.93)
Black tea ~0
Weekly
Daily
1 [Reference]
0.97 (0.86-1.09)
0.86 (0.74-1.00)
Green tea ~0
Weekly
Daily
1 [Reference]
1.05 (0.93-1.18)
1.12 (0.98-1.29)
Fuhrman et al,15 2009,
Puerto Rico (Puerto
Rico Heart Health
Program)
M 35-79 4685 519 2.6
(median)
SR Age, BMI, smoking,
family history of
DM, education,
alcohol, PA, milk
and sugar intakes
Coffee 0
1-2
3
4
0.64 (0.43-0.94)
1 [Reference]
0.79 (0.69-1.00)
0.75 (0.58-0.97)
Hamer et al,17 2008,
United Kingdom
(Whitehall II study)
M and F 35-55 5823 387 11.7 SR Age, sex, ethnicity,
employment
grade, BMI, WHR,
smoking,
sex-specific
alcohol intake, PA,
family history of
DM, HT,
cholesterol, total
energy intake, diet
pattern, mutual
adjustment for all
beverage types
Coffee 0
1
2-3
3
1 [Reference]
0.83 (0.60-1.14)
0.85 (0.60-1.20)
0.80 (0.54-1.18)
Decaf
coffee
0
1
2-3
3
1 [Reference]
1.13 (0.87-1.47)
0.87 (0.58-1.30)
0.65 (0.36-1.16)
Tea 0
1
2-3
3
1 [Reference]
1.08 (0.75-1.56)
0.81 (0.56-1.17)
0.77 (0.52-1.140
Bidel et al,14 2008,
Finland
M 35-74 10 666 483 NR Age, BMI, alcohol,
smoking, PA, GGT
Coffee 0-2
3-4
5-6
7
1 [Reference]
0.89 (0.68-1.18)
0.87 (0.67-1.13)
0.71 (0.53-0.94)
F 35-74 11 160 379 0-2
3-4
5-6
7
1 [Reference]
0.75 (0.57-0.98)
0.63 (0.47-0.83)
0.47 (0.33-0.69)
Smith et al,23 2006,
United States
(Rancho Bernardo
Study)
M and F 50 910 84 8.3 OGTT Age, sex, PA, BMI,
smoking, alcohol,
HT, FPG
Coffee 0
1-2
3-4
5
1 [Reference]
0.66 (0.38-1.14)
0.53 (0.26-1.08)
0.60 (0.26-1.40)
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estimates) with information on
457922 participants reported on the
associationbetween coffee consump-
tion and subsequent risk of DM.
There was evidence of a significant
inverse log-linear association such
that every additional cup of coffee
consumed in a day was associated
with a 7% reduction in the excess
risk of DM (RR, 0.93 [95%CI, 0.91-
0.95]) (P .001) (Figure2). In cat-
egorical analysis, the pooled sum-
mary estimate from these studies
indicated that drinking 3 to 4 cups
of coffee per daywas associatedwith
Table. Characteristics of Studies Reporting on the Association Between Coffee, Decaffeinated Coffee, or Tea
and Subsequent Type 2 DM (continued)
Source Sex
Age
Range,
y
Study Size,
No. of
Subjects
DM
Event,
No.
Follow-up,
y
Assessment
of DM
Variables
in Multiple
Adjustment Beverage Consumptiona
Multivariate
Adjusted
RR
(95% CI)
Paynter et al,21 2006,
United States
(ARIC study)
M 45-64 5414 718 12 SR Age, race, education,
family history of
DM, BMI, WHR,
total caloric intake,
dietary fiber,
smoking, alcohol,
leisure PA, HT
Coffee Almost never
1
1
2-3
4
1 [Reference]
0.94 (0.74-1.18)
1.04 (0.83-1.30)
0.82 (0.66-1.03)
0.77 (0.61-0.98)
F 45-64 6790 719 Almost never
1
1
2-3
4
1 [Reference]
0.91 (0.71-1.16)
1.90 (0.73-1.10)
0.92 (0.75-1.14)
0.89 (0.69-1.15)
Pereira et al,22 2006,
United States (Iowa
Women’s Health
Study)
F 55-69 28 812 1418 11 SR Age, education,
baseline HT,
alcohol, smoking,
BMI, WHR, PA,
energy intake, total
fat, Keys score,
cereal fiber, tea,
soda
consumption,
magnesium,
phytate
Coffee 0
1
1-3
4-5
6
1 [Reference]
0.95 (0.77-1.18)
1.01 (0.85-1.19)
0.85 (0.69-1.04)
0.79 (0.61-1.02)
Coffee 0
1
1-3
4-5
6
1 [Reference]
0.92 (0.76-1.11)
0.88 (0.70-1.12)
0.89 (0.64-1.23)
1.00 (0.84-1.19)
Decaf
coffee
0
1
1-3
4-5
6
1 [Reference]
0.98 (0.83-1.16)
1.01 (0.84-1.21)
0.59 (0.44-0.80)
0.68 (0.43-1.09)
Hu et al,18 2006,
Finland
M 35-74 10 188 517 13.4 NR Age, study year,
education, SBP,
bread, vegetable,
fruit, sausage,
coffee, tea,
alcohol, smoking,
PA, BMI
Tea 0
1-2
3
1 [Reference]
0.89 (0.71-1.11)
0.83 (0.59-1.17)
F 35-74 11 197 447 13.4 NR Tea 0
1-2
3
1 [Reference]
0.92 (0.74-1.15)
0.85 (0.57-1.27)
Iso et al,19 2006,
Japan ( Japan
Collaborative Cohort
Study for Evaluation
of Cancer Risk)
M 40-65 6727 231 5 SR Age, BMI, family
history of DM,
smoking, alcohol,
magnesium, PA,
consumption of
other beverages
Coffee 1
1-2
3
1 [Reference]
0.96 (0.68-1.36)
0.54 (0.30-0.97)
Black tea 1
1
1 [Reference]
1.43 (0.56-3.64)
Green tea 1
1-2
3-5
6
1 [Reference]
0.82 (0.47-1.41)
1.12 (0.71-1.76)
0.91 (0.55-1.52)
F 40-65 10 686 213 5 SR Coffee 1
1-2
3
1 [Reference]
0.88 (0.61-1.25)
0.61 (0.30-1.22)
Black tea 1
1
1 [Reference]
0.80 (0.49-1.32)
Green tea 1
1-2
3-5
6
1 [Reference]
0.66 (0.40-1.08)
0.61 (0.41-0.91)
0.49 (0.30-0.79)
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an approximate 25% lower risk of
DM thandrinking none or 2 or fewer
cups per day (RR, 0.76 [95% CI,
0.69-0.82]) (Figure 3). There was
evidence of significant heteroge-
neity across studies (P=.01) thatwas
not explained by differences in the
strength of effect between men and
women (RR, 0.78 [95% CI, 0.70-
0.87] and 0.71 [95% CI, 0.62-
0.81], respectively) (P= .24 for
heterogeneity); the regionwhere the
study was conducted (Europe RR,
0.84 [95% CI, 0.75-0.94] vs the
United States RR, 0.73 [95% CI,
0.62-0.85]) (P= .15 for heteroge-
neity); or the method of diagnosis
(national register or oral glucose tol-
erance test RR, 0.85 [95% CI, 0.74-
0.98] vs self-report RR, 0.72 [95%
CI, 0.66-0.79]) (P=.05 for hetero-
geneity).
Restriction of the analysis to those
11 studies that reported both age-
and sex-adjusted estimates and es-
timates that were adjusted for other
potential confounders (Table) indi-
cated that the observed association
was unaffected by the level of ad-
justment in the crude model (RR,
Table. Characteristics of Studies Reporting on the Association Between Coffee, Decaffeinated Coffee, or Tea
and Subsequent Type 2 DM (continued)
Source Sex
Age
Range,
y
Study Size,
No. of
Subjects
DM
Event,
No.
Follow-up,
y
Assessment
of DM
Variables
in Multiple
Adjustment Beverage Consumptiona
Multivariate
Adjusted
RR
(95% CI)
van Dam et al,24 2006,
USA (Nurses’
Health Study II)
F 26-46 88 259 1263 10 SR Age, BMI, PA,
smoking, alcohol,
use of hormone
therapy, oral
contraceptives,
family history of
type 2 DM, history
of HT, history of
hypercholesterol-
emia, sugar-
sweetened soft
drinks, punch,
quintiles of
processed meat,
polyunsaturated to
saturated fat intake
ratio, total energy
intake, glycemic
index, cereal fiber
intake
Total
coffee
0
1
1
2-3
4
1 [Reference]
0.93 (0.80-1.09)
0.87 (0.73-1.03)
0.58 (0.49-0.68)
0.53 (0.41-0.68)
Coffee 0
1
1
2-3
4
1 [Reference]
1.00 (0.86-1.17)
0.89 (0.75-1.07)
0.62 (0.52-0.74)
0.61 (0.43-0.81)
Decaf
coffee
0
1
1
2
1 [Reference]
0.86 (0.74-0.99)
0.87 (0.68-1.11)
0.52 (0.36-0.74)
Tea 0
1
1
2-3
4
1 [Reference]
0.97 (0.83-1.12)
1.17 (0.97-1.40)
0.98 (0.79-1.20)
0.88 (0.64-1.23)
Greenberg et al,16
2005, United States
(NHANES-1)
M and F 32-88 7006 309 8.4 SR Per capita income,
education level,
race, sex, PA,
smoking, alcohol,
BMI, age, diet
Coffee 0
2
2-4
4
1 [Reference]
0.82 (0.55-1.23)
0.75 (0.50-1.13)
0.37 (0.22-0.64)
Decaf
coffee
0
2
2
1 [Reference]
0.62 (0.34-1.11)
0.43 (0.20-0.93)
Tea 0
2
1-2
2
1 [Reference]
0.76 (0.54-1.09)
0.67 (0.36-1.28)
0.34 (0.15-0.76)
Song et al,36 2005,
United States (The
Woman’s Health
Study)
F 45 38 018 1614 8.8 SR Age, BMI, total energy
intake, smoking,
exercise, alcohol,
history of HT,
history of high
cholesterol, family
history of DM, fiber
intake, glycemic
load, magnesium,
and total fat intake
Tea 0
1
1-3
4
1 [Reference]
1.07 (0.95-1.21)
1.05 (0.91-1.21)
0.72 (0.52-1.01)
(continued)
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0.75 [95% CI, 0.67-0.85]) vs in the
maximally adjustedmodel (RR, 0.76
[95% CI, 0.70-0.84]) (P= .81 for
heterogeneity).
There was some evidence of pub-
lication bias found by the Egger test
(P=.08) such that the smaller stud-
ies tended to report greater effect
sizes than did the larger studies
(P=.01 for trend) (Figure 4). The
summary risk estimate from the 6
largest estimates (defined as hav-
ing a statistical study weight 35)
of drinking 3 to 4 cups of coffee per
day compared with drinking none
or fewer than 2 cups per daywas RR,
0.85 (95%CI, 0.75-0.96),while from
the 7 smallest estimates (defined as
having a statistical study weight
20), it was RR, 0.62 (95%CI, 0.48-
0.79).
Table. Characteristics of Studies Reporting on the Association Between Coffee, Decaffeinated Coffee, or Tea
and Subsequent Type 2 DM (continued)
Source Sex
Age
Range,
y
Study Size,
No. of
Subjects
DM
Event,
No.
Follow-up,
y
Assessment
of DM
Variables
in Multiple
Adjustment Beverage Consumptiona
Multivariate
Adjusted
RR
(95% CI)
Carlsson et al,31 2004,
Finland (Finnish
Twin Cohort)
M and F 30-60 10 652 408 20 NR Age, sex, BMI,
education, leisure
time PA, alcohol,
smoking
Coffee 2
3-4
5-6
7
1 [Reference]
0.70 (0.48-1.01)
0.71 (0.50-1.01
0.65 (0.44-0.96)
van Dam et al,38 2004,
the Netherlands
(Hoorn Study)
M and F 50-74 1312 128 6 OGTT Age, sex, BMI, WHR,
PA, alcohol,
smoking, history
of CVD, use of
antihypertensive
medication,
intake of fiber,
total energy,
saturated fat,
polyunsaturated
fat
Coffee 2
3-4
5-6
7
1 [Reference]
0.94 (0.54-1.09)
0.92 (0.53-1.61
0.69 (0.31-1.51)
Rosengren et al,33
2004, Sweden
(BEDA study)
F 39-65 1361 74 18 SR and NR Age, smoking, low
PA, education,
BMI, serum
cholesterol,
triglycerides
Coffee 2
3-4
5-6
6
1 [Reference]
0.56 (0.32-0.98)
0.45 (0.23-0.90)
0.57 (0.26-1.29
Salazar-Martinez
et al,34 2004, United
States (Health
Professionals
Follow-up Study and
Nurses’ Health
Study)
M 40-75 41 934 1333 12 SR Age, BMI, PA, total
caloric intake,
family history of
DM, alcohol,
smoking, intakes
of glycemic load,
trans-fat,
polyunsaturated
fatty acid, cereal
fiber, magnesium
Coffee 0
1
1-3
4-5
6
1 [Reference]
0.98 (0.84-1.15)
0.93 (0.80-1.08)
0.71 (0.53-0.94)
0.46 (0.26-0.82)
Decaf
coffee
0
1
1-3
4
1 [Reference]
0.95 (0.84-1.08)
0.91 (0.76-1.03)
0.74 (0.48-1.12)
Tea 0
1
1-3
4
1 [Reference]
0.92 (0.81-1.04)
0.97 (0.82-1.14)
1.02 (0.59-1.78)
F 30-55 84 276 4085 18 SR Age, BMI, PA, total
caloric intake,
family history of
DM, alcohol,
smoking,
menopausal
status and
postmenopausal
hormone use,
intakes of
glycemic load,
trans-fat,
polyunsaturated
fatty acid, cereal
fiber, magnesium
Coffee 0
1
1-3
4-5
6
1 [Reference]
1.16 (1.05-1.29)
0.99 (0.90-1.08)
0.70 (0.60-0.82)
0.71 (0.56-0.89)
Decaf
coffee
0
1
1-3
4
1 [Reference]
0.96 (0.88-1.05)
0.88 (0.80-0.97)
0.85 (0.61-1.17)
Tea 0
1
1-3
4
1 [Reference]
1.05 (0.97-1.15)
1.01 (0.92-1.11)
0.91 (0.72-1.16)
(continued)
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ASSOCIATION BETWEEN
DECAFFEINATED COFFEE
CONSUMPTION AND
SUBSEQUENT RISK OF DM
Six studies (N=225 516 partici-
pants) reported on the association
between decaffeinated coffee con-
sumption and subsequent risk of
DM. The pooled summary esti-
mates from these studies indicated
that individuals who drank more
than 3 to 4 cups of decaffeinated cof-
fee per day had an approximate one-
third lower risk of DM than those
consuming no decaffeinated coffee
(RR, 0.64 [95% CI, 0.54-0.77])
(Figure 3). There was little evi-
dence for either significant hetero-
geneity across included studies
(P=.31) or publication bias (P=.57
for Egger test).
ASSOCIATION BETWEEN TEA
CONSUMPTION AND
SUBSEQUENT RISK OF DM
A total of 7 studies (N=286701 par-
ticipants) reported on the associa-
tion between tea consumption and
subsequent risk of DM. Pooled sum-
mary estimates indicated that indi-
viduals who drank more than 3 to 4
cups of tea per day had an approxi-
mate one-fifth lower risk of DM than
those consuming no tea (RR, 0.82
[95% CI, 0.73-0.94]) (Figure 3).
There was little evidence for signifi-
cant heterogeneity across included
studies(P=.46)andnoevidenceto in-
dicate thepresenceofpublicationbias
(P=.11 for Egger test). For studies of
teaanddecaffeinatedcoffee, therewas
insufficientdatatopermitexamination
ofadose-responserelation. Itwasalso
notpossible to examine thepotential
effectof confoundingontherelation-
ship because none of the studies re-
ported both age- and multivariate-
adjusted estimates.
COMMENT
The findings from this meta-
analysis, based on over 500 000 in-
dividuals with over 21 000 cases of
new-onset DM, confirm an inverse
associationbetween coffee consump-
tion and subsequent risk of DM: ev-
ery additional cup of coffee con-
sumed in a day was associated with
5% to 10% lower risk of incidentDM
after adjustment for potential con-
founders. However, this may be an
overestimate of the true magnitude
of the association owing to the pres-
ence of small-study bias.
Furthermore, in the first over-
view ofwhichwe are aware, wewere
able to demonstrate similar inverse
associations between consumptionof
decaffeinated coffee and teawith risk
1.0
0.8
0.7
0.6
0.5
<1 1-2 3-4 5-6 >6
Coffee Consumption, Cups/d
Re
la
tiv
e 
Ri
sk
P for trend <.001
Figure 2. The relationship between coffee consumption and subsequent type 2 diabetes mellitus in
different categories of coffee consumption. The center of each black square is placed at the summary
point estimate; the area of the square is proportional to the statistical size; and each vertical line shows
the 95% confidence interval about the summary estimate.
Table. Characteristics of Studies Reporting on the Association Between Coffee, Decaffeinated Coffee, or Tea
and Subsequent Type 2 DM (continued)
Source Sex
Age
Range,
y
Study Size,
No. of
Subjects
DM
Event,
No.
Follow-up,
y
Assessment
of DM
Variables
in Multiple
Adjustment Beverage Consumptiona
Multivariate
Adjusted
RR
(95% CI)
Reunanen et al,32
2003, Finland
(Mobile Clinic
Health Examination
Survey)
M and F 20-98 19 518 855 16 NR Age, sex, BMI,
smoking, leisure
time PA
Coffee 2
3-4
5-6
7
1 [Reference]
1.01 (0.81-1.27)
0.98 (0.79-1.21)
0.92 (0.73-1.16)
Saremi et al,35 2003,
United States (Pima
Indians Study)
M and F 15 2680 824 11 OGTT Age, sex, BMI Coffee 0
1-2
3
1 [Reference]
0.92 (0.74-1.13)
1.01 (0.82-1.26)
Tea Unrelated to
incidences
of DM
van Dam et al,39 2002,
the Netherlands
M and F 30-60 17 111 306 7 SR Age, sex, town, BMI,
lifestyle, CVD, HT,
hypercholesterol-
emia
Coffee 2
3-4
5-6
7
1 [Reference]
0.79 (0.57-1.10)
0.73 (0.53-1.01)
0.50 (0.35-0.72)
Abbreviations: ARIC, Atherosclerosis Risk in Communities study; BMI, body mass index (calculated as weight in kilograms divided by height in meters
squared); CI, confidence interval; CVD, cardiovascular disease; decaf, decaffeinated; DM, diabetes mellitus; FPG, fasting plasma glucose level;
GGT, gamma glutamyltransferase; HT, hypertension; JPHC, Japan Public Health Center–based study; NHANES, National Health and Nutrition Examination Survey;
NR, national register; OGTT, oral glucose tolerance test; PA, physical activity; RR, risk ratio; SBP, systolic blood pressure; SR, self-report; WHR, waist to hip ratio.
aUnless otherwise indicated, consumption is measured in cups per day.
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of incident DM. For example, indi-
viduals consumingmore than 3 to 4
cups of tea a dayhad aone-fifth lower
risk of subsequent DM than non–
tea drinkers; those consuming a simi-
lar amountofdecaffeinatedcoffeehad
a one-third lower risk than noncon-
sumers. However, in the study by
Greenberg and colleagues,16 con-
sumption of decaffeinated coffeewas
associatedwith a significant 40% re-
duction in the risk of DM only in
those aged 60 years or younger. In
older individuals, the direction of as-
sociationwas reversed such that there
was a significant 40% increase in risk.
The observed age-related effect may
have been a statistical artifact driven
by subgroup analysis. However, we
were unable to examine the effect by
age, and the possibility that the as-
sociationbetween coffee andDMrisk
is age dependent warrants further
investigation.
That the apparent protective
effect of tea and coffee consump-
tion appears to be independent of a
number of potential confounding
variables raises the possibility of di-
rect biological effects. Our findings
suggest that any protective effects of
coffee and tea are unlikely to be
solely effects of caffeine, but rather,
as has been speculated previously,
they likely involve a broader range
of chemical constituents present in
0.3 0.5 1.0 1.5
Relative Risk
Coffee
Smith et al,23 2006
Iso et al,19 2006 (F)
Iso et al,19 2006 (M)
Rosengren et al,33 2004 (F)
Greenberg et al,16 2005
van Dam et al,38 2004
Hamer et al,17 2008
Carlsson et al,31 2004
van Dam et al,39 2002
Kato et al,40 2009 (F)
Salazar-Martinez et al,34 2004
Odegaard et al,20 2008
Bidel et al,14 2008 (M)
Bidel et al,14 2008 (F)
Fuhrman et al,15 2009 (M)
Paynter et al,21 2006 (F)
van Dam,24 2006 (F)
Paynter et al,21 2006 (M)
Reunanen et al,32 2003
Saremi et al,35 2003
Pereira et al,22 2006 (F)
Kato et al,40 2009 (M)
Salazar-Martinez et al,34 2004 (F)
Total
Decaffeinated coffee
Greenberg et al,16 2005
Hamer et al,17 2008
Salazar-Martinez et al,34 2004 (M)
van Dam,24 2006
Salazar-Martinez et al,34 2004 (F)
Pereira et al,22 2006 (F)
Total
Tea
Greenberg et al,16 2005
Salazar-Martinez et al,34 2004 (M)
Hu et al,18 2006 (F)
Hamer et al,17 2008
Hu et al,18 2006 (M)
Song et al,36 2005
van Dam,24 2006
Salazar-Martinez et al,34 2004 (F)
Total
Source
Lowest
(Referent) Other
Consumption, cups/d
0
<1
<1
≤2
0
≤2
0
≤2
≤2
0
0
0
0-2
0-2
1-2
0
0
0
≤2
0
0
0
0
3-4
3-4
3-4
3-4
≥4
3-4
≥4
3-4
3-4
3-4
4-5
≥4
3-4
3-4
≥4
≥4
≥4
≥4
3-4
≥3
4-5
3-4
4-5
0
0
0
0
0
0
≥2
≥4
≥4
≥2
≥4
4-5
0
0
0
0
0
0
0
0
≥3
≥4
≥3
≥4
≥3
≥4
≥4
≥4
RR, 0.76 (95% CI, 0.69-0.82)
I2 = 45% (95% CI, 17%-67%)
Pheter = .01
RR, 0.64 (95% CI, 0.54-0.77)
I2 = 16% (95% CI, 1%-79%)
Pheter = .31
RR, 0.84 (95% CI, 0.73-0.94)
I2 = 1% (95% CI, 1%-66%)
Pheter = .46
Figure 3. Association between coffee, decaffeinated coffee, and tea consumption and subsequent type 2 diabetes mellitus in published cohort studies (adjusted in
all cases at least for age, sex, and body mass index). The studies are sorted by statistical size, defined by the inverse of the variance of the relative risk (RR). The
center of each black square is placed at the point estimate; the area of the square is proportional to the statistical size; and each horizontal line shows the 95%
confidence interval (CI) for the estimate for each study. Pheter indicates P value for heterogeneity.
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these beverages, such as magne-
sium,41 lignans,42 and chlorogenic ac-
ids.43 The effects of these coffee com-
ponents on glucosemetabolism and
insulin sensitivity from both ani-
mal studies and in vitro experi-
ments have been extensively re-
viewed elsewhere.44 While these
components have been demon-
strated to have beneficial effects on
biological pathways intimately in-
volved in glucose homeostasis and
insulin secretion, how these find-
ings relate to in vivo effects in hu-
mans is uncertain. Because most of
the studies included in this review
did not provide data on the effects
of these beverages or their compo-
nents on measures of hyperglyce-
mia and insulin sensitivity, we can-
not provide further evidence on the
mechanisms involved. In studies that
reported data on insulin sensitiv-
ity, findings were conflicting, with
some suggesting that coffee use in-
creased sensitivity to insulin,38,45
while others reported no effect.46
There have been few randomized
trials of the effects of coffee on glu-
cose and insulin, but 1 randomized
crossover trial of 4 weeks’ duration
of high coffee consumption re-
ported an increase in fasting insu-
lin levels but no effect on fasting glu-
cose concentration.47
Possiblemechanisms of action for
tea on DM may involve 1 or more
physiologic pathways. For example,
tea catechins have been shown to in-
hibit the carbohydrate digestive en-
zymes, which suggests that glucose
production may be decreased in the
gastrointestinal system resulting in
lower levels of glucose and insu-
lin.48 Black, green, and oolong tea
have also been reported to increase
insulin sensitivity by increasing in-
sulin-stimulated glucose uptake in
adipocytes.49 There has also been the
suggestion that green tea may pre-
vent damage to pancreatic beta
cells.50,51 There have been several
small clinical intervention studies
conducted that have examined the ef-
fects of tea consumption on biomar-
kers of glucoregulatory control, but
the results from these studies have
been inconsistent. Some studies have
reported a significant reduction in
plasma glucose and hemoglobin A1c
levels,52,53 while others have re-
ported no effect on any aspect of glu-
coregulatory control.54 Given that di-
etary polyphenols are rapidly meta-
bolized, one explanation for the
discrepant findings between these
studies may have been the measure-
ment of the effects of tea on biomar-
kers at different times after its con-
sumption. For example, catechin
concentrations in human plasma
reach theirmaximum level at 2hours
after ingestionof green teabut areun-
detectable after 24 hours.55
That there is a causal inverse as-
sociation between coffee consump-
tion and subsequent riskofDMis fur-
ther supported by the presence of a
dose-response relationship. In those
consuming more than 6 cups of cof-
fee per day, the risk of new-onsetDM
was reduced by approximately 40%
comparedwith non–coffee drinkers,
while among those who drank less
than 1 cup per day, the risk was only
marginally reduced to about 4%com-
pared with coffee abstainers. More-
over, estimates were quite similar
across studies despite the diversity in
populations. Of note, this similarity
was presence in spite of the likely
presence of marked variation be-
tween studies in types of coffee and
tea and their preparation (eg, fil-
tered vs unfiltered, cup size, cup
strength, addition of milk or sugar,
and other variations). Finally, the re-
sults were consistent between stud-
ies regardless of which method of
diagnosis of DM was used (ie, self-
report vs national register or oral glu-
cose tolerance test).
An inherent weakness of all
observational studies and meta-
analyses thereof is the possibility that
any association is due to the pres-
ence of confounding. However, be-
cause high levels of coffee and tea
consumption have been reported to
be associatedwith risk behaviors that
are positively associatedwith the risk
of developing DM (such as low lev-
els of physical activity56 and ciga-
rette smoking57), it might be specu-
lated that adjustment for such risk
factors would strengthen the rela-
tionship as has been reported. We
examined the impact of confound-
ing on the relationship between cof-
fee consumption and subsequent
risk of DM by comparing crude and
adjusted estimates of effect fromonly
those studies that reported both es-
timates and observed that adjust-
ment for potential confounders had
no material impact (either a
strengthening or a weakening) on
the estimate of effect. However, we
were unable to conduct a similar
analysis for tea consumption be-
cause studies only reported the ad-
justed estimate. Tea drinkersmay be
more health conscious than coffee
drinkers, and it is therefore plau-
sible that some of the observed ben-
eficial effect of tea onDM risk is due
in part to other health-promoting be-
haviors (eg, regular physical activ-
ity, weight maintenance, and non-
smoking) that may or may not have
been taken into consideration in the
original studies.
A furthermajor limitation of this
analysis is the reliance on pub-
lished data, which precluded more
detailed analysis of the effect of ad-
justment for confounders at an in-
dividual level or for specific con-
founders separately. In this regard,
it is possible that individuals who
consume extreme quantities of cof-
fee differ in other important di-
0.5 1
Relative Risk
Statistical
size of study Estimates People
Small
Medium
Large
7
10
6
33 825
259 165
164 932
Test for
trend
χ1 = 6.32
Ptrend = .01
Overall
2
Figure 4. Impact of study size on summary estimates of the relative risk between coffee consumption
and subsequent type 2 diabetes mellitus adjusted in all cases at least for age, sex, and body mass index.
The center of each black square is placed at the summary point estimate; the area of the square is
proportional to the statistical size; and each horizontal line shows the 95% confidence interval about the
summary estimate.
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etary and sociologic aspects from
more moderate coffee consumers,
but to examine this issue any fur-
therwould require an individual par-
ticipant data meta-analysis. There-
fore, the possibility that coffee
consumptionmay be acting as a sur-
rogate marker of some other di-
etary or lifestyle risk factor cannot
be fully excluded.
Finally, although the studies in-
cluded in this review were all pop-
ulation based, only 20% of the
cohorts were from nonwhite popu-
lations, which somewhat limits the
generalizability of the study findings
to largelyWestern populations. This
is an important consideration given
that thepatternofbeverage consump-
tion and background risk ofDMmay
differ across ethnic groups.
In conclusion, high intake of cof-
fee, decaffeinated coffee, and/or tea
is associated with a material reduc-
tion in the risk of new-onset DM. If
such beneficial effects were ob-
served in interventional trials to be
real, the implications for the mil-
lions of individualswhohaveDM, or
who are at future risk of developing
it, would be substantial. For ex-
ample, the identification of the ac-
tive components of these beverages
wouldopenupnew therapeutic path-
ways for the primary prevention of
DM. It could also be envisaged that
we will advise our patients most at
risk for DM to increase their con-
sumption of tea and coffee in addi-
tion to increasing their levels of physi-
cal activity and weight loss.
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